Among experienced physicians, neurologists are reportedly more comfortable than pediatricians in treating people with Rett syndrome, according to a…
Articles by Patricia Inácio, PhD
Leriglitazone, an oral treatment candidate for neurological diseases, can improve the function of mitochondria — known as the powerhouse of…
TSHA-102, an experimental gene therapy for Rett syndrome now being tested in clinical trials, has been granted fast track…
Acadia Pharmaceuticals has expanded its licensing agreement with Neuren Pharmaceuticals to commercialize Daybue (trofinetide) — the first and only…
Levels of anxiety and depression in girls and women with Rett syndrome are influenced both by the individual’s type…
The recent U.S. approval of Daybue (trofinetide) as the first treatment for adults and children with Rett syndrome…
The hands and feet of people with Rett syndrome have a lower skin temperature than people without the disease,…
The U.S. Food and Drug Administration (FDA) has given “positive” feedback to Unravel Biosciences‘ regarding a proof-of-concept study…
Taysha Gene Therapies is recruiting women with Rett syndrome for the REVEAL Phase 1/2 study that will test…
A set of proteins in the cerebrospinal fluid (CSF) — the fluid that flows around the brain and spinal cord…